Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $129.3000 (1.02%) ($129.3000 - $129.5600) on Fri. Jul. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 57 | Latest Price | $129.3000(1.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). VIXM(-26%) VXX(-16%) UUP(-16%) IGOV(-6%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $130.06 | 5 Day Moving Average | $129.74(-0.34%) | 10 Day Moving Average | $132.44(-2.37%) | 20 Day Moving Average | $130.06(-0.58%) | To recent high | -15.7% | To recent low | 14.5% | Market Cap | $2.078b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |